More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$174405000
P/E ratio
19.6
Dividend yield
1.0303%
Expense ratio
0.47%
Beta
0.962048
Previous close
$31.17
Today's open
$31.44
Day's range
$31.44 - $32.02
52 week range
$20.38 - $32.02
Industries
Health
6.86%
6.28%
IPN:PA
Ipsen Sa
5.23%
4502:TK
Takeda Pharmaceutical Co Ltd
4.49%
BAYN:SG
Bayer Ag
4.36%
4.15%
GSK:LN
GSK plc
4.12%
22UA:FF
Biontech Se
4.07%
3.99%
EXEL
Exelixis Inc
3.8%
Medical Technology Stocks: Innovation Endures As Valuations Reset
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.
Seeking Alpha • May 2, 2026

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.
Seeking Alpha • Apr 12, 2026

Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Seeking Alpha • Nov 11, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Seeking Alpha • May 30, 2025

IDNA: The Cutting Edge Of Medical Science Is A Risky Investment
The iShares Genomics Immunology and Healthcare ETF is invested in 49 companies involved in genomics, immunology and bioengineering. Compared with the biotechnology benchmark IBB, IDNA has value characteristics, but has greatly underperformed, losing over 20% since its inception. Among genomics-focused ETFs, PBE offers a relatively safer choice with better performance and lower volatility.
Seeking Alpha • Apr 20, 2025

Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Seeking Alpha • Feb 25, 2025

Disruptive Theme of the Week – Breakthroughs in Medicine
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.
ETF Trends • Nov 21, 2024

IDNA: Healthcare Dashboard For February
This article provides a monthly dashboard with aggregate industry metrics in the healthcare sector. Fast facts on IDNA, a thematic and volatile biotech ETF. We conclude with 10 healthcare stocks cheaper than their peers in February.
Seeking Alpha • Feb 18, 2024

Disruptive Tech Theme of the Week: 7 Disruptive Themes for 2024
To use a holiday analogy, I have been checking lists and checking them twice to figure out which of next year's top disruptive investment themes are likely to be nice.
ETF Trends • Dec 18, 2023

VettaFi Voices On: Accessing Disruptive Innovation
Good Morning, VettaFi Voices! Disruptive innovation is a popular topic, and it encompasses everything from bitcoin and cryptocurrency to electric vehicles to artificial intelligence.
ETF Trends • Nov 17, 2023

¹ Disclosures

Open an M1 investment account to buy and sell iShares Genomics Immunology and Healthcare ETF commission-free¹. Build wealth for the long term using automated trading and transfers.